Literature DB >> 31049674

Residual pulmonary hypertension is associated with clinical outcomes in patients with acute pulmonary thromboembolism.

Tatsuro Ibe1, Hiroshi Wada2, Kenichi Sakakura1, Seiichiro Yoshimura1, Miyuki Ito1, Yusuke Ugata1, Kei Yamamoto1, Masaru Seguchi1, Yousuke Taniguchi1, Shin-Ichi Momomura1, Hideo Fujita1.   

Abstract

In patients with acute pulmonary thromboembolism (PTE), the influence of residual pulmonary hypertension (PH) has not been well investigated. The aim of this study was to compare clinical characteristics between patients with and without residual PH, and to investigate the association between residual PH and clinical outcomes after acute phase in acute PTE. We included acute PTE patients who underwent echocardiogram after acute phase between January 2009 and December 2016. These patients were divided into residual PH and non-residual PH groups according to the value of estimated right ventricular systolic pressure (eRVSP) by echocardiogram after acute phase (the residual PH group: eRVSP ≥ 40 mmHg, the non-residual PH group: eRVSP < 40 mmHg). Kaplan-Meier survival curves were applied to investigate whether the residual PH were associated with PTE-related death or recurrent PTE in patients with acute PTE. A total of 49 patients with acute PTE were allocated into the residual PH group (n = 10) and non-residual PH group (n = 39). Median follow-up period for 49 patients was 7 months. The event-free survival rate was significantly lower in the residual PH group as compared with the non-residual PH group (p = 0.003), whereas there was no statistical significance between two groups stratified by initial PH or not (p = 0.97). Residual PH after acute phase was significantly associated with mid-term PTE-related death or recurrent PTE in patients with acute PTE.

Entities:  

Keywords:  Acute thromboembolism; Estimated right ventricular systolic pressure; Pulmonary hypertension; Residual pulmonary hypertension

Mesh:

Year:  2019        PMID: 31049674     DOI: 10.1007/s00380-019-01420-2

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  16 in total

1.  Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)

Authors:  S Z Goldhaber; L Visani; M De Rosa
Journal:  Lancet       Date:  1999-04-24       Impact factor: 79.321

2.  Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association.

Authors:  Michael R Jaff; M Sean McMurtry; Stephen L Archer; Mary Cushman; Neil Goldenberg; Samuel Z Goldhaber; J Stephen Jenkins; Jeffrey A Kline; Andrew D Michaels; Patricia Thistlethwaite; Suresh Vedantham; R James White; Brenda K Zierler
Journal:  Circulation       Date:  2011-03-21       Impact factor: 29.690

3.  2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism.

Authors:  Stavros V Konstantinides; Adam Torbicki; Giancarlo Agnelli; Nicolas Danchin; David Fitzmaurice; Nazzareno Galiè; J Simon R Gibbs; Menno V Huisman; Marc Humbert; Nils Kucher; Irene Lang; Mareike Lankeit; John Lekakis; Christoph Maack; Eckhard Mayer; Nicolas Meneveau; Arnaud Perrier; Piotr Pruszczyk; Lars H Rasmussen; Thomas H Schindler; Pavel Svitil; Anton Vonk Noordegraaf; Jose Luis Zamorano; Maurizio Zompatori
Journal:  Eur Heart J       Date:  2014-08-29       Impact factor: 29.983

4.  Association of persistent right ventricular dysfunction at hospital discharge after acute pulmonary embolism with recurrent thromboembolic events.

Authors:  Stefano Grifoni; Simone Vanni; Simone Magazzini; Iacopo Olivotto; Alberto Conti; Maurizio Zanobetti; Gianluca Polidori; Filippo Pieralli; Nazerian Peiman; Cecilia Becattini; Giancarlo Agnelli
Journal:  Arch Intern Med       Date:  2006-10-23

Review 5.  Pulmonary microvascular disease in chronic thromboembolic pulmonary hypertension.

Authors:  Nazzareno Galiè; Nick H S Kim
Journal:  Proc Am Thorac Soc       Date:  2006-09

6.  Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction.

Authors:  S Grifoni; I Olivotto; P Cecchini; F Pieralli; A Camaiti; G Santoro; A Conti; G Agnelli; G Berni
Journal:  Circulation       Date:  2000-06-20       Impact factor: 29.690

7.  Epidemiological and outcome data in Japanese patients with deep vein thrombosis with and without malignancy.

Authors:  Kensuke Yokoi; Masahiko Hara; Yasunori Ueda; Keiichi Yamamoto; Keiko Ota; Daijiro Kabata; Tetsuhisa Kitamura; Yasushi Sakata; Ayumi Shintani
Journal:  Heart Vessels       Date:  2017-07-24       Impact factor: 2.037

8.  Pulmonary embolism: one-year follow-up with echocardiography doppler and five-year survival analysis.

Authors:  A Ribeiro; P Lindmarker; H Johnsson; A Juhlin-Dannfelt; L Jorfeldt
Journal:  Circulation       Date:  1999-03-16       Impact factor: 29.690

9.  High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension.

Authors:  Timothy A Morris; James J Marsh; Peter G Chiles; Marisa M Magaña; Ni-Cheng Liang; Xavier Soler; Daniel J Desantis; Debby Ngo; Virgil L Woods
Journal:  Blood       Date:  2009-05-06       Impact factor: 22.113

10.  Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism.

Authors:  Vittorio Pengo; Anthonie W A Lensing; Martin H Prins; Antonio Marchiori; Bruce L Davidson; Francesca Tiozzo; Paolo Albanese; Alessandra Biasiolo; Cinzia Pegoraro; Sabino Iliceto; Paolo Prandoni
Journal:  N Engl J Med       Date:  2004-05-27       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.